FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   JOSEPH WETTENY 2. Date of Event Requiring Statement (Month/Day/Year) 10/13/2015 3. Issuer Name and Ticker or Trading Symbol Catalent, Inc. [CTLT] (Last) (First) (Middle) C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) See Remarks 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) SOMERSET, NJ 08873 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 5,383 (1) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock	  (2)	10/23/2019	Common Stock	8,120	$ 10.7143	D	Â
Options to purchase common stock	  (3)	10/23/2019	Common Stock	8,120	$ 10.7143	D	Â
Options to purchase common stock	  (4)	06/25/2023	Common Stock	12,460	$ 18.7143	D	Â
Options to purchase common stock	  (5)	06/25/2023	Common Stock	2,492	$ 18.7143	D	Â
Options to purchase common stock	  (6)	07/30/2024	Common Stock	10,849	$ 20.5	D	Â
Options to purchase common stock	  (7)	08/27/2025	Common Stock	6,515	$ 31.96	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
JOSEPH WETTENY C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET, NJ 08873	Â	Â	  See Remarks	Â

Signatures

/s/ Steven Fasman, by power of attorney		10/15/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes restricted stock units.
(2)	On October 23, 2009, the reporting person was granted an option to purchase 8,120 shares of common stock of the Issuer, which vested and became exercisable in five equal annual installments beginning on October 23, 2010.
(3)	On October 23, 2009, the reporting person was granted an option to purchase 8,120 shares of common stock of the Issuer, which vested and became exercisable in five equal annual installments beginning on October 23, 2010.
(4)	On June 25, 2013, the reporting person was granted an option to purchase 12,460 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on June 23, 2014.
(5)	On June 25, 2013, the reporting person was granted an option to purchase 12,460 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018. The performance criteria for 2014 and 2015 were met, resulting in vesting of the option as to 4,984 shares. The option is currently exercisable for 2,492 shares.
(6)	On July 30, 2014, the reporting person was granted an option to purchase 10,849 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on July 30, 2015.
(7)	On August 27, 2015, the reporting person was granted an option to purchase 6,515 shares of common stock of the Issuer, which vest and become exercisable in four equal annual installments beginning on August 27, 2016.
  Remarks: President - Clinical Supply Services Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.